SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

ZATELLI, Maria Chiara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.819
AS - Asia 15.360
EU - Europa 14.031
SA - Sud America 2.409
AF - Africa 327
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 13
Totale 58.986
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.188
FI - Finlandia 6.237
SG - Singapore 5.898
CN - Cina 3.621
DE - Germania 1.914
BR - Brasile 1.867
IT - Italia 1.688
VN - Vietnam 1.653
HK - Hong Kong 1.260
UA - Ucraina 1.164
GB - Regno Unito 786
TR - Turchia 727
BD - Bangladesh 625
FR - Francia 502
RU - Federazione Russa 489
JP - Giappone 403
SE - Svezia 327
IN - India 316
PL - Polonia 307
CA - Canada 281
MX - Messico 244
AR - Argentina 205
ID - Indonesia 204
NL - Olanda 148
ZA - Sudafrica 126
IQ - Iraq 104
PK - Pakistan 100
ES - Italia 93
EC - Ecuador 82
CO - Colombia 66
AT - Austria 64
BE - Belgio 59
VE - Venezuela 58
UZ - Uzbekistan 53
LT - Lituania 48
PH - Filippine 46
SA - Arabia Saudita 46
MA - Marocco 43
CL - Cile 42
MY - Malesia 42
AE - Emirati Arabi Uniti 33
KE - Kenya 30
IE - Irlanda 27
PY - Paraguay 27
TN - Tunisia 26
JO - Giordania 24
UY - Uruguay 24
AU - Australia 23
EG - Egitto 23
PE - Perù 22
DZ - Algeria 20
JM - Giamaica 20
IL - Israele 19
AL - Albania 18
CH - Svizzera 18
NP - Nepal 18
CZ - Repubblica Ceca 16
DO - Repubblica Dominicana 16
CR - Costa Rica 15
AZ - Azerbaigian 14
GR - Grecia 14
KR - Corea 14
LB - Libano 14
TH - Thailandia 14
DK - Danimarca 13
ET - Etiopia 13
PS - Palestinian Territory 13
RO - Romania 13
BO - Bolivia 12
IR - Iran 12
OM - Oman 12
PA - Panama 12
PT - Portogallo 12
KZ - Kazakistan 11
LV - Lettonia 11
EU - Europa 10
BH - Bahrain 8
GT - Guatemala 8
HN - Honduras 8
MD - Moldavia 8
NG - Nigeria 8
SY - Repubblica araba siriana 8
BG - Bulgaria 7
GA - Gabon 7
HU - Ungheria 7
KG - Kirghizistan 7
TT - Trinidad e Tobago 7
CY - Cipro 6
PR - Porto Rico 6
TW - Taiwan 6
AM - Armenia 5
AO - Angola 5
BY - Bielorussia 5
HR - Croazia 5
KH - Cambogia 5
RS - Serbia 5
SK - Slovacchia (Repubblica Slovacca) 5
BA - Bosnia-Erzegovina 4
LK - Sri Lanka 4
MK - Macedonia 4
Totale 58.907
Salva come PNG Salva come JPEG
Città #
Helsinki 5.843
Singapore 3.698
Ashburn 3.617
Woodbridge 2.086
San Jose 2.067
Fairfield 1.883
Chandler 1.487
Jacksonville 1.274
Houston 1.248
Hong Kong 1.245
Santa Clara 1.202
Beijing 1.125
Ann Arbor 842
Seattle 759
Wilmington 709
Cambridge 627
Ho Chi Minh City 536
New York 515
Los Angeles 480
Dallas 414
Izmir 412
Tokyo 389
Hanoi 382
Nanjing 375
Munich 363
Princeton 313
Lauterbourg 308
Warsaw 298
Council Bluffs 279
Addison 276
Ferrara 261
Milan 244
São Paulo 205
Shanghai 191
San Diego 187
Boardman 186
Mexico City 164
Jakarta 141
Orem 128
Buffalo 123
Turku 122
Shenyang 119
London 118
Nanchang 112
Dearborn 101
Chennai 99
Chicago 95
Bremen 94
Brooklyn 93
Montreal 92
Hefei 88
Tianjin 88
Hebei 85
Denver 84
Rome 82
Toronto 79
Da Nang 76
Atlanta 73
Bologna 73
Moscow 73
Frankfurt am Main 72
Changsha 70
Haiphong 69
Johannesburg 68
Phoenix 67
Washington 67
Boston 64
The Dalles 62
Stockholm 61
San Francisco 58
Manchester 57
Mountain View 56
Jiaxing 55
Falls Church 52
Jinan 52
Rio de Janeiro 51
Amsterdam 50
Nuremberg 49
Poplar 49
Brussels 48
Baghdad 45
Guangzhou 45
Tashkent 45
Kunming 44
Falkenstein 43
Belo Horizonte 41
Hải Dương 40
Lappeenranta 39
Norwalk 39
Redwood City 38
Ankara 36
Biên Hòa 34
Mumbai 34
Quito 31
Naples 30
Brasília 29
Campinas 29
Tappahannock 29
Charlotte 28
Curitiba 28
Totale 40.632
Salva come PNG Salva come JPEG
Nome #
Metodo per modulare la proliferazione del carcinoma midollare della tiroide (MTC) 1.984
Composti farmaceutici che inibiscono la proliferazione di adenomi ipofisari e modi d’uso che ne derivano 1.957
Uso di inibitori delle Cicloossigenasi di tipo 2 come agenti atti a modificare la farmacoresistenza cellulare 1.957
SRC homology-2-containing protein tyrosine phosphatase-1 restrains cell proliferation in human medullary thyroid carcinoma 433
Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds 324
Applicability of laparoscopic approach to the resection of large adrenal tumours: a retrospective cohort study on 200 patients 303
8th edition of the AJCC/TNM staging system of thyroid cancer: What to expect (ITCO#2) 291
Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas 288
Role of Ultrasonographic/Clinical Profile, Cytology, and BRAF V600E Mutation Evaluation in Thyroid Nodule Screening for Malignancy: A Prospective Study 279
Proposal for a novel management of indeterminate thyroid nodules on the basis of cytopathological subclasses 278
A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization 266
Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression 264
Igf-I influences everolimus activity in medullary thyroid carcinoma 262
Relevance of BRAF(V600E) Mutation Testing Versus RAS Point Mutations and RET/PTC Rearrangements Evaluation in the Diagnosis of Thyroid Cancer 260
Evaluation of the Role of BRAFV600E Somatic Mutation on Papillary Thyroid Cancer Disease Persistence: A Prospective Study 258
An in vivo OctreoScan-negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro 254
Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism 253
Cyclin D1 levels are involved in the resistance to m-TOR inhibitors in human bronchial carcinoids 253
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids 249
Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory 245
Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer cell lines 243
Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives. 241
Recettori della somatostatina e carcinoma midollare della tiroide: prospettive future. 240
BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies 240
Increase in Peripheral CD3-CD56brightCD16- Natural Killer Cells in Hashimoto's Thyroiditis Associated with HHV-6 Infection 239
Predictors of Pituitary Dysfunction in Patients Surviving Ischemic Stroke 235
Magmas Overexpression Inhibits Staurosporine Induced Apoptosis in Rat Pituitary Adenoma Cell Lines 233
Inhibition of epithelial growth factor receptor can play an important role in reducing cell growth and survival in adrenocortical tumors 233
Is there a correlation between BRAFV600 mutation, sentinel lymph node biopsy, pathological and clinical parameters in papillary thyroid carcinoma? 233
Functional characterization of a new deletion in CDKN1B 5'-UTR region 231
Effects of two mTOR inhibitors on in-vitro models of GH-secreting pituitary adenomas 231
Adrenal cavernous hemangioma: a case report 230
Early onset acromegaly associated with a novel deletion in CDKN1B 5'UTR region 228
Allelic discrimination in the diagnosis of somatic BRAF V600E mutation on fine-needle aspiration biopsies 226
Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells 226
RET mutation profile and variable clinical manifestations in a family with multiple endocrine neoplasia type 2A and Hirschsprung's disease 225
Evaluation of hormonal function in a series of incidentally discovered adrenal masses 224
Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto’s thyroiditis 223
The cytotoxic effect of sunitinib on human bronchial carcinoid cell lines and primary cultures is counteracted by EGF and IGF-1 but not by VEGF 223
mTOR, AKT, p70S6K and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 222
X-linked acrogigantism syndrome: clinical profile and therapeutic responses 220
Radio-guided selective compartment neck dissection improves staging in papillary thyroid carcinoma: a prospective study on 345 patients with a 3-year follow-up. 219
Acute administration of human galanin in normal subjects reduces the potentiating effect of pyridostigmine-induced cholinergic enhancement on release of norepinephrine and pancreatic polypeptide 218
Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone (GH)- releasing hormone function 218
Presenza di HHV-6 in campioni tiroidei di pazienti con malattie autoimmuni della tiroide 218
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression 218
Magmas, a Novel Over-Expressed Gene in Pituitary Rat Cell Lines and in Human Pituitary Adenomas: A New Pituitary Biomarker? 218
Epidermal growth factor pathway as a possible target in the medical therapy of bronchial carcinoids 215
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 213
BRAFV600E analysis on fine needle aspiration biopsy increases diagnostic accuracy for papillary thyroid cancer in clinically unsuspected nodules 213
Growth hormone induces chemoresistance in breast cancer cells 213
N-carbamidoyl-4-((3-ethyl-2,4,4-trimethylcyclohexyl)methyl)benzamide enhances staurosporine cytotoxic effects likely inhibiting the protective action of Magmas toward cell apoptosis 213
Involvement of PKCβ and PKCδ isoforms in TSH signaling pathway in thyroid cancer cell lines 212
Growth hormone excess promotes breast cancer chemoresistance 211
Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 211
Identification of differentially expressed microRNAs by microarray: A possible role for microRNA genes in pituitary adenomas 209
Cushing in a Leaf: Endocrine Disruption From a Natural Remedy 208
Efficacy and Safety of Teriparatide in Beta-Thalassemia Major Associated Osteoporosis: A Real-Life Experience 207
EGF and IGF1 affect sunitinib activity in BP-NEN: New putative targets beyond VEGFR? 206
Three-Dimensional Primary Cell Culture: A Novel Preclinical Model for Pancreatic Neuroendocrine Tumors 205
Differential mTOR and PI3K Pathway Activation in Human Bronchial Carcinoids 205
Characteristics of a nationwide cohort of patients presenting with isolated hypogonadotropic hypogonadism (IHH) 204
Neck paraganglioma and follicular lymphoma: A case report 204
Antiproliferative effects of somatostatin analogs in pituitary adenomas 202
IGF-I Proliferative Effects Are Inhibited by Targeting PKC in Human Endocrine Tumor Cells 202
miR-15a and miR-16-1 down-regulation in pituitary adenomas 202
MTOR inhibitors response and mTOR pathway in pancreatic neuroendocrine tumors 202
Deletion of exons 1-3 of the MEN1 gene in a large Italian family causes the loss of menin expression 202
Mitotane enhances doxorubicin cytotoxic activity by inhibiting P-gp in human adrenocortical carcinoma cells 202
Magmas, a Gene Newly Identified as Overexpressed in Human and Mouse ACTH-Secreting Pituitary Adenomas, Protects Pituitary Cells from Apoptotic Stimuli 201
Should aip gene screening be recommended in family members of FIPA patients with R16H variant? 201
R171Q MEN1 polymorphism in patients presenting with hyperparathyroidism 201
Therapeutic concentrations of mitotane (o,p′-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line model 200
Acromegaly secondary to an incidentally discovered growth-hormone-releasing hormone secreting bronchial carcinoid tumour associated to a pituitary incidentaloma 199
Magmas, a novel over-expressed gene in Pituitary rat cell lines and in human pituitary adenomas: a new pituitary bio marker? 199
HypoparaNet: A Database of Chronic Hypoparathyroidism Based on Expert Medical-Surgical Centers in Italy 197
An unusual association of hyperparathyroidism, ectopic GHRH secrection and bronchial carcinoid in a MEN1 family 196
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression. 196
HHV-6A in vitro infection of thyrocytes and T cells alters the expression of miRNA associated to autoimmune thyroiditis 196
Chromogranin A as a marker of neuroendocrine neoplasia: An Italian Multicenter Study 194
A new VHL polymorphism in a big family from Ferrara 193
Unexpected activation of pituitary-adrenal axis in healthy young and elderly subjects during somatostatin infusion 191
Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines 191
Efficacy, safety and adherence to treatment of teriparatide: an observational study 190
A tool to predict survival in stage IV entero-pancreatic NEN 190
VEGF autocrine secretion is enhanced by EGFR activation trough ERK1/2 phosphorylation in human adrenocortical carcinoma cell lines 189
Efficacy of tolvaptan treatment in a patient with syndrome of inappropriate antidiuresis (SIAD) after severe traumatic brain injury 188
Growth Hormone Enhances Breast Cancer Chemoresistance by Inhibiting JNK-Mediated Apoptosis 187
Clinical value of different responses of serum thyroglobulin to recombinant human thyrotropin in the follow-up of patients with differentiated thyroid carcinoma 187
Atypical femoral fractures as a complication of long-term bisphosphonate therapy 186
Bronchial carcinoid response to mTOR inhibitors depends on mTOR expression levels 186
mTOR, p70S6K, AKT and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 186
Dual-energy X-ray absorptiometry pitfalls in Thalassemia Major 185
mTOR mediated IGF1 proliferative effects on a rat pituitary GH/PRL secreting pituitary adenoma cell line 185
Glucose metabolism alterations in acromegaly 184
Pituitary side effects of old and new drugs. 184
Protein Kinase C: A Putative New Target for the Control of Human Medullary Thyroid Carcinoma Cell Proliferation in Vitro 182
Evaluation of bone markers and structure in subclinical Cushing’s syndrome 182
Utilization of luminescent technology to develop a kinase assay: Cdk4 as a model system 182
Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet) 182
Totale 27.284
Salva come PNG Salva come JPEG
Categoria #
all - tutte 249.393
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 11.228
Totale 260.621
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021175 0 0 0 0 0 0 0 0 0 0 0 175
2021/20222.754 113 256 179 54 118 160 129 151 114 223 266 991
2022/20233.186 321 277 130 435 467 440 168 266 385 26 165 106
2023/20242.076 151 193 103 57 138 315 56 454 58 47 49 455
2024/20257.639 206 165 605 202 929 796 221 311 1.250 974 1.108 872
2025/202628.473 1.974 846 1.797 2.606 3.387 1.455 2.938 1.326 7.721 2.572 1.158 693
Totale 59.593